ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0351

Gene Signature Fingerprints Divide SLE Patients in Subgroups with Similar Biological Disease Profiles: A Multicenter Longitudinal Study

Javad Wahadat1, Dieneke Schonenberg-Meinema2, Cornelia van Helden-Meeuwsen1, Sander van Tilburg1, Noortje Groot3, Ellen Schatorjé4, Esther Hoppenreijs4, Petra Hissink Muller5, Danielle Brinkman6, Denis Dvorak7, Marleen Verkaaik3, Katerina Bouchalova8, Merlijn van den Berg2, Sylvia Kamphuis9 and Marjan Versnel1, 1Erasmus University Medical Center, Rotterdam, Netherlands, 2Emma Children's Hospital, Amsterdam University Medical Center, Amsterdam, Netherlands, 3Sophia Children's Hospital, Erasmus University Medical Center, Rotterdam, Netherlands, 4Amalia Children's Hospital, Nijmegen, Netherlands, 5Willem Alexander Children’s Hospital, Leiden University Medical Center, Leiden, Netherlands, 6Willem Alexander Children’s Hospital, Leiden University Medical Center, Leiderdorp, Netherlands, 7Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital, Olomouc, Czech Republic, 8Department of Pediatrics, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic, 9Sophia Children’s Hospital, Erasmus University Medical Center, Rotterdam, Netherlands

Meeting: ACR Convergence 2021

Keywords: Biomarkers, Gene Expression, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 6, 2021

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster I: Diagnosis (0323–0356)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Clinical phenotyping and predicting treatment responses in Systemic Lupus Erythematosus (SLE) patients is challenging. Extensive blood transcriptional profiling has identified various gene modules that seem promising for stratification of SLE patients. This study was undertaken to translate transcriptomic data into gene signatures suitable for introduction into clinical practice and to associate these signatures with disease activity.

Methods: RT-PCR of multiple genes from the Interferon M1.2, Interferon M5.12, neutrophil (NPh)- and plasma cell (PLC) modules followed by a principle component analysis was used to identify indicator genes per gene signature. Gene signatures were measured in longitudinal samples from two childhood onset SLE cohorts (n=101 and n=34, respectively) and associated with clinical features. Disease activity was measured using SELENA-SLEDAI. Cluster analysis subdivided patients into three fingerprint groups termed 1) all-signatures-low, 2) only IFN high (M1.2 and/or M5.12) and 3) high NPh and/or PLC.

Results: All gene signatures were significantly associated with disease activity in cross-sectionally collected samples. The PLC signature showed the highest association with disease activity. Also, in longitudinally collected samples, the PLC signature was associated with disease activity and showed a decrease over time. When patients were divided into fingerprints, the highest disease activity was observed in the high NPh and/or PLC group. The lowest disease activity was observed in the all-signatures-low group. The same distribution could be reproduced in samples from an independent SLE cohort.

Conclusion: Gene signatures are associated with disease activity and can be suitable tools to sub-classify SLE patients into groups with similar pathogenically activated immunological pathways.


Disclosures: J. Wahadat, None; D. Schonenberg-Meinema, None; C. van Helden-Meeuwsen, None; S. van Tilburg, None; N. Groot, None; E. Schatorjé, None; E. Hoppenreijs, None; P. Hissink Muller, None; D. Brinkman, None; D. Dvorak, None; M. Verkaaik, None; K. Bouchalova, None; M. van den Berg, None; S. Kamphuis, GlaxoSmithKline, 7, Aurinia, 2; M. Versnel, None.

To cite this abstract in AMA style:

Wahadat J, Schonenberg-Meinema D, van Helden-Meeuwsen C, van Tilburg S, Groot N, Schatorjé E, Hoppenreijs E, Hissink Muller P, Brinkman D, Dvorak D, Verkaaik M, Bouchalova K, van den Berg M, Kamphuis S, Versnel M. Gene Signature Fingerprints Divide SLE Patients in Subgroups with Similar Biological Disease Profiles: A Multicenter Longitudinal Study [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/gene-signature-fingerprints-divide-sle-patients-in-subgroups-with-similar-biological-disease-profiles-a-multicenter-longitudinal-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gene-signature-fingerprints-divide-sle-patients-in-subgroups-with-similar-biological-disease-profiles-a-multicenter-longitudinal-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology